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SUMMARY: The microcystin-degrading gene cluster, mlrA-B-C-D, plaies an important role in the degradation process of 
hepatotoxic microcystins for several bacterial species. However after microcystin is degraded to linear-microcystin by 
MlrA, it is still unknown about where and by what it is metabolited. In order to clarify it, we disrupted the mlrB gene and 
mlrC gene in chromosome of microcystin-degrading bacteria, Sphingopyxis sp. C-1. The cells disrupted mlrB gene and 
mlrC gene accumulated of microcystin-degradation product, linear-microcystin and tetrapeptide, respectively, whereas the 
cell free extracts of ∆mlrB cells detected Adda and ∆mlrC cells accumulated tetrapeptide. Moreover, topology analysis of 
MlrB using the ß-lactamase gene fusion method insisted MlrB is the peripheral protein binding the inner-membrane. These 
results insist that MlrB degrades the linear microcystin in the periplasmic space and MlrC degrades tetrapeptide in 
cytoplasm. Thus, in intact cells, MlrC cannot degrade linear-microcystin as being separated in inner-membrane from linear-
microcystin while MlrC is capable of degrading the linear-microcystin in cell-free extract. 
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 INTRODUCTION 
 Microcystins are produced in rather high pH by 
cyanobacteria belonging to the genera Microcystis, 
Anabaena, Oscillatoria and Nostoc, and are hepatotoxic 
compounds with cyclic heptapeptides resulting in the death 
of fishes, birds, many kinds of domestic animals and human 
[1]. In natural water, biodegradation is main factor of 
decrease in microcystins [2], which concering gene factors 
mlrA, mlrB, mlrC, and mlrD [3]   
 In the degradation pathway, we and other groups 
reported MlrA is the first enzyme to hydrolyze cyclic 
microcystin LR into a linear intermediate by biochemical 
and genetic assays. Reacently, some groups reported that 
mlrB would not function from genome analysis in silico. 
But the E. coli cells overexpressed mlrB or mlrC degrades 
the linear microcystin using the cell free extracts and mlrB 
was verified to function experimentally. But we don’t know 
whether MlrB or MlrC is mainly attributable to degrade the 
linear microcystin in cells.  
 This study reports the reason why C-1 cells have both 
enzymes for degradation of linear-microcystin, and in other 
words, the reason why mlrC doesn’t degrade the linear-
microcystin in intact cells and the reason that mlrB and 
mlrC mainly contribute to degrade the linear-microcystin 
and the tetrapeptide, respectively. 
 
2. MATERIALS AND METHODS 
2.1 Bacterial strains 
 Spingopyxis sp. C-1 was used as microcystin-
degradating bacterium. Escherichia coli DH5α was the host 
in the DNA manipulation. 
 
2.2 Microcystin Degradation Activity.  
 Degradation of microcystin and the degradation product 
were assayed by high-performance liquid chromatography 
(JASCO 2000 Series; JASCO international Co., Ltd, Japan) 
using a Sun Fire TMC18 column (3.0 × 150 mm; particle 
size, 5.0 μm; Waters, Milford, MA, USA) at 40ºC. 
 
2.2 Gene modification and DNA techniques.  
 Deletions of chromosomal genes were conducted by 
recombination [4, 5]. To obtain blaM gene inserted mlrB 
gene to mlrB genes, EZ-Tn5 <blaM/R6Kγori> transposon 
(Epicentre) was used. Other molecular biological techniques 
were followed by the standard procedures described 
previously or follows the manufacture's instruction [5]. 
 
3. RESULTS AND DISCUSSION 
3.1 Disruption of mlrB gene in chromosome of C-1 
strain 
 In the degradation pathway, MlrA was shown to be a 
first enzyme to hydrolyze cyclic microcystin LR into a 
linear intermediate, a linear microcystin LR. The MlrB 
protein was speculated to hydrolyze linear microcystin LR 
into a tetrapeptide, which would later be degraded by MlrC. 
To clear this presumption, we disrupted the mlrB gene in 
chromosome of C-1 strain yielding C1-∆mlrB and verified 
whether the linear microcystin LR was degradated in C1-
∆mlrB. Disruption of chromosomal mlrB gene led to 
accumulate the linear microcystin LR, MlrA degradation 
product, whereas C-1 cells degradated the microcystin LR 
completely for 6.5 h.  
3.2 Contribution of MlrC in decomposing microcystin 
LR 
 The results obtained in 3.2 indicated that MlrB is 
necessary for degradation but MlrC would not be likely to 
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contribute to degrade the linear-microcystin in cells. To 
conferim this speculation, we disrupted mlrC gene in 
chromosome of wild-type strain and C1-∆mlrB mutant 
yielding C1-∆mlrC and C1-∆mlrB∆mlrC, respectively, and 
measured the degradative activities of linear-microcystin 
and tetrapeptide in cells, with companying degradation of 
microcystin. In C1-∆mlrC strain, the disruption of mlrC 
gene led to accumulate the tetrapeptide. On one hand, in 
C1-∆mlrB∆mlrC strain, the linear-microcystin accumulated. 
Moreover, when tetra-peptide was added into C1-∆mlrB 
cell suspension as a substrate, tetra-peptide decreased 
immediately, but not in C1-∆mlrB∆mlrC cells at all. This 
result indicates that MlrC functions in cells and degrades 
tetra-peptide in cells. When linear-microcystin was added 
into C1-∆mlrC suspension, it was degraded and decreased 
immediately, but not suitably in C1-∆mlrB∆mlrC cells at 
all. 
 In the next experiments, to clear that MlrC being in cell 
is incapable of degrading the linear-microcystin, we 
measured the degradative activities in preparing the cell free 
extract of C1-∆mlrB and C1-∆mlrB∆mlrC strains. 
Unexpectedly, the cell free extract of C1-∆mlrB showed 
clear degradative activity of linear-microcystin and 
tetrapeptide, but that of C1-∆mlrB∆mlrC didn’t do. This 
result indicated that MlrC is expressing in cytosol and have 
functions that degrade the linear-microcystin and 
tetrapeptide, but only a degradative activity of the linear-
microcystin was depressed in intact cells by some kind of 
reasons. One possibility is that the linear-microcystin is 
separated from MlrC by inner-membrane because MlrA and 
MlrB are predicted to have a signal sequence by 
SOSUISignal program, though MlrC doesn’t have clear 
signal sequence and is located in cytosol. 
 
3.3 Construction and Expression of the Reporter Gene, 
mlrB-BlaM Fusion 
 To determine where the MlrB functions, we constructed 
mlrB-blaM fusions as described in “materials and method.” 
We obtained total 34 independent fusion genes using the 
transposon insertional method and PCR method. To 
ascertain proper expression of the hybrid proteins in the E. 
coli host, we employ SDS-PAGE of the 34 cell free extracts 
prepared from the cells harboring the plasmids, and the 
proteins were visualized by the immunoblotting method 
using an antibody raised against ampicillinase. The result 
depicted that the hybrid proteins from P23-BlaM through 
P541-BlaM were lined up in increasing molecular mass as 
the fusion sites became more distal from the carboxyl-
terminal end. The size of all hybrid proteins was consistent 
with the size predicted from the length of the truncated 
MlrB plus the size of the reporter protein, BlaM. Next, we 
determined carbenicillin susceptibility of the cells harboring 
the mlrB-blaM fusion gene to ascertain the localization of 
the hybrid proteins. Because the strains expressing the 
MlrB-BlaM hybrid protein in the periplasm are expected to 
be β-lactam-resistant, whereas the strains carrying the fusion 
in the cytoplasm will be β-lactam-susceptible. The 34 
transformants carrying the mlrB-blaM fusion exhibited the 
MICs of carbenicillin 128 μg/ml to more than 256 μg/ml. 
The MIC of carbenicillin for the host cell harboring 
pHSG398 without BlaM fusion appeared to be 4 μg/ml and 
the site of fusion is located in periplasmic space. Moreover, 
generally, the gaps between one fusion site to the nearest 
neighboring sites were consistently less than 21 amino acid 
residues for the membrane topology analysis because about 
20 amino acid residues need to span from outside of 
membrane to inside. These results clearly suggested that the 
entire MlrB polypeptide would be located at the periplasmic 
space. 
 Finally, to ensure our hypothesis, we construct the 
MlrC-BlaM fusion protein, which was fused ß-lactamase to 
carbonyl terminal of MlrC protein, and measured the 
degradating activity and susceptibility to carbenicillin in 
that transformant. As I had expected, the transformants 
carrying the plasmid coding the MlrC-BlaM hybrid protein 
exhibited resistant to carbenicillin and those cell-free 
extracts had the degradating activity of linear-microcystin 
and tetra-peptide, suggesting that MlrC functions in cytosol. 
 
4. CONCLUSION 
This study revealed the degradation pathway of 
microcystins in the cell that MlrA firstly hydrolyzed cyclic 
microcystin LR into a linear intermediate, and MlrB 
degraded the linear microcystin in the periplasmic space, 
and then MlrC degraded tetrapeptide in cytoplasm. 
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